{
  "abstract": "Retatrutide, a triple action treatment for type 2 diabetes, could significantly reduce blood glucose concentrations and body weight in patients with the condition, a phase 3 trial has reported.",
  "authors": [
    {
      "affiliations": [
        "Bristol"
      ],
      "name": "Katharine Lang"
    }
  ],
  "title": "Retatrutide: Triple acting jab for type 2 diabetes lowers blood sugar and boosts weight loss, trial reports",
  "uid": "d5c6cd52-68d6-520e-b70a-5fa349431106"
}